CME Group Inc. $CME Shares Sold by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. reduced its holdings in CME Group Inc. (NASDAQ:CME) by 62.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 66,317 shares of the financial services provider’s stock after selling 111,082 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in CME Group were worth $17,374,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in CME. Diversify Advisory Services LLC increased its holdings in shares of CME Group by 1.7% during the third quarter. Diversify Advisory Services LLC now owns 41,415 shares of the financial services provider’s stock valued at $11,988,000 after purchasing an additional 689 shares during the period. MBM Wealth Consultants LLC lifted its holdings in CME Group by 25.1% in the third quarter. MBM Wealth Consultants LLC now owns 2,339 shares of the financial services provider’s stock worth $613,000 after purchasing an additional 469 shares during the period. Net Worth Advisory Group lifted its holdings in CME Group by 29.7% in the third quarter. Net Worth Advisory Group now owns 3,466 shares of the financial services provider’s stock worth $919,000 after purchasing an additional 793 shares during the period. Kenora Financial LLC bought a new position in CME Group in the 3rd quarter valued at about $221,000. Finally, CWA Asset Management Group LLC grew its position in CME Group by 0.7% in the 3rd quarter. CWA Asset Management Group LLC now owns 7,988 shares of the financial services provider’s stock valued at $2,093,000 after buying an additional 52 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on the stock. UBS Group boosted their price target on shares of CME Group from $270.00 to $310.00 and gave the stock a “neutral” rating in a research report on Thursday. Raymond James Financial reiterated an “outperform” rating and issued a $320.00 price objective on shares of CME Group in a report on Thursday, July 2nd. Weiss Ratings upgraded shares of CME Group from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. CLSA set a $367.00 price objective on shares of CME Group in a research note on Thursday. Finally, The Goldman Sachs Group dropped their target price on CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a report on Tuesday, June 30th. Ten analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $313.29.

Insider Buying and Selling at CME Group

In other news, Director Martin Gepsman sold 400 shares of CME Group stock in a transaction that occurred on Thursday, October 22nd. The shares were sold at an average price of $302.50, for a total value of $121,000.00. Following the transaction, the director owned 25,244 shares of the company’s stock, valued at $7,636,310. The trade was a 1.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Elizabeth Cook sold 500 shares of the business’s stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $280.11, for a total transaction of $140,055.00. Following the completion of the sale, the director owned 17,916 shares in the company, valued at $5,018,450.76. The trade was a 2.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 15,900 shares of company stock worth $4,377,655. 0.30% of the stock is currently owned by company insiders.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record quarterly results: CME reported third-quarter revenue of approximately $1.74 billion, up 10.6% year over year and above the $1.71 billion consensus estimate. EPS of $3.02 also exceeded expectations of $2.99, while average daily volume reached a record 29.4 million contracts. CME third-quarter revenue article
• Positive Sentiment: Crypto derivatives momentum: CME recorded approximately $469.5 billion in crypto derivatives volume during the third quarter, highlighting growing demand for regulated digital-asset products. The company has not separately disclosed crypto revenue, so the direct earnings contribution remains unclear. CME crypto derivatives volume article
• Positive Sentiment: More bullish analyst coverage: JPMorgan upgraded CME from “underweight” to “overweight” and set a $367 price target, citing improving volume and earnings prospects. Wells Fargo also raised its target to $333. JPMorgan CME rating
• Positive Sentiment: Expansion opportunities: CME plans to launch CME Securities Clearing on December 7, potentially broadening its clearing business. Management also highlighted strong participation and international volume growth. CME Securities Clearing article
• Neutral Sentiment: Valuation remains debated: UBS lifted its price target from $270 to $310 but retained a “neutral” rating, indicating that much of the improved outlook may already be reflected in the stock. UBS CME rating
• Negative Sentiment: Insider sale: Director Martin Gepsman sold 400 shares for approximately $121,000. The transaction reduced his holdings by 1.56%, but he still owns 25,244 shares, limiting the sale’s significance. CME director stock sale

CME Group Trading Down 0.1%

Shares of CME stock opened at $305.71 on Friday. The stock has a 50-day simple moving average of $277.60 and a 200 day simple moving average of $270.74. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The stock has a market capitalization of $109.93 billion, a P/E ratio of 25.08, a P/E/G ratio of 3.92 and a beta of 0.24. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.99 by $0.03. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The firm had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.71 billion. During the same period in the previous year, the company earned $2.68 earnings per share. CME Group’s revenue was up 10.6% compared to the same quarter last year. On average, sell-side analysts expect that CME Group Inc. will post 12.36 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th were given a dividend of $1.30 per share. The ex-dividend date was Wednesday, September 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. CME Group’s dividend payout ratio (DPR) is 42.66%.

CME Group Company Profile

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.